Trulieve CannabisTRLV -0.35%63 Gross Margin % is 59.31% as of Mar. 2026, which is 2% below its 10-year median of 60.56. GuruFocus rates TRLV with a GF Score™ of 63/100 and a GF Value™ of $6.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, Trulieve Cannabis ranks better than 68.23% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Trulieve Cannabis had a gross margin of 59.31% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Trulieve Cannabis Gross Margin % Related Terms
Trulieve Cannabis Gross Margin % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Trulieve Cannabis (TRLV) has a Gross Margin % of 59.31% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Trulieve Cannabis and its competitors. This is near median its historical median of 60.56. Over the past decade, Trulieve Cannabis' Gross Margin % has ranged from 52.13 to 78.23. According to the industry distribution chart, Trulieve Cannabis ranks #298 out of 938 companies in the Drug Manufacturers industry, placing it in the top 31.8%.
Is Trulieve Cannabis' Gross Margin % too high?
Trulieve Cannabis' current Gross Margin % of 59.31% is near median its 10-year median of 60.56. Over the past 10 years, this metric has ranged from a low of 52.13 to a high of 78.23. The Drug Manufacturers industry median Gross Margin % is 48.44. Trulieve Cannabis' value of 59.31% is 22.4% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #298 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #298 out of 938 companies for Gross Margin %. This puts Trulieve Cannabis in the upper half of its industry. The industry median Gross Margin % is 48.44. Trulieve Cannabis' value of 59.31% is 22.4% above this benchmark. Historically, Trulieve Cannabis' own Gross Margin % has ranged from 52.13 to 78.23 over the past decade. While the company's 10-year median is 60.56 vs. the industry median of 48.44, Trulieve Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current Gross Margin % of 59.31% is 22.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Gross Margin % is 59.31%, which is near median its own 10-year median of 60.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (TRLV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.03, compared to a current price of $8.50 — trading 41% above its estimated fair value. The current Gross Margin % is 59.31%, which is near median its 10-year median of 60.56 and 22.4% above the Drug Manufacturers industry median of 48.44. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Trulieve Cannabis (TRLV), the current Gross Margin % is 59.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (TRLV) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for TRLV:
Gross Margin %: 59.31% (near median its 10-year median of 60.56)
GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
Industry Position: 22.4% above the Drug Manufacturers median (#298 of 938)
No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for TRLV
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRLV has been successfully added to your 
